Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UVIC INDUSTRY PARTNERSHIPS INC. currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This level of activity suggests a multi-faceted approach to securing its intellectual property. The company is actively engaged in responding to these outstanding matters to move its applications toward issuance.
The prosecution of these applications is distributed across 3 distinct examiners and 3 distinct art units. This one-to-one ratio between examiners and art units indicates a diverse portfolio where applications are being evaluated in different technical contexts. Navigating 3 distinct art units requires the company to address a range of departmental standards and examination protocols.
WHITE, DENNIS MICHAEL is designated as the busiest examiner for the portfolio. This examiner is currently handling 1 busiest examiner pending office action. Because each of the 3 pending office actions is assigned to a different person, WHITE, DENNIS MICHAEL only oversees a portion of the active workload. This distribution means that the company's prosecution strategy must be adaptable to the 3 distinct examiners currently reviewing its filings.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, DENNIS MICHAEL | 1 | 58.0% | +48.6% |
| GRABER, JAMES J | 1 | 46.7% | +57.7% |
| PATTERSON, SARAH COOPER | 1 | 55.3% | +59.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18360442 | MICROFLUIDIC DEVICE WITH INTEGRATED MAGNETS FOR BIOMARKER DETECTION AND MANIPULATION | WHITE, DENNIS MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767687 | Chimeric Cytokine Receptors | GRABER, JAMES J | 26d |
| 17642089 | ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHODS OF USING SAME | PATTERSON, SARAH COOPER | 46d |
| 18360442 | MICROFLUIDIC DEVICE WITH INTEGRATED MAGNETS FOR BIOMARKER DETECTION AND MANIPULATION | WHITE, DENNIS MICHAEL | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1631 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18360442 | MICROFLUIDIC DEVICE WITH INTEGRATED MAGNETS FOR BIOMARKER DETECTION AND MANIPULATION | WHITE, DENNIS MICHAEL | 1758 | §102§103 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17767687 | Chimeric Cytokine Receptors | GRABER, JAMES J | 1631 | §103DP | Final Rejection | 26d | Pending | Apr 08, 2022 |
| 17642089 | ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHODS OF USING SAME | PATTERSON, SARAH COOPER | 1675 | §112Other | Final Rejection | 46d | Pending | Mar 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial